13F filer · CIK 1603466 ↗
Point72
You are looking at Q3 2022. See the latest, Q2 2026 →
Reported value
$25.04B
+5.6% on the quarter before
Positions
1,372
485 new · 491 sold out
Top 10
11.3%
of the value
Est. gain
−$341.0M
on stocks held all quarter
Est. return
−2.8%
on those stocks since Q2 2022
Positions as of Sep 30, 2022, from Point72's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 21% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2022. Striped tiles are options.
Largest buys
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Biogen Inc~$326.3MAdded · 0.4% → 1.8%+1,222,182 shares
- Alibaba~$234.6MAdded · 0.3% → 1.1%+2,932,273 shares
- Palo Alto Networks~$195.2MAdded · 0.5% → 0.9%+1,191,688 shares
- Workday~$161.6MNew · 0.0% → 0.6%+1,061,911 shares
- Astrazeneca Plc~$155.7MAdded · 0.5% → 1.1%+2,839,681 shares
- Dell Technologies Inc~$139.3MNew · 0.0% → 0.6%+4,076,922 shares
- Gsk Plc~$136.0MNew · 0.0% → 0.5%+4,621,851 shares
- Microsoft~$133.1MAdded · 0.4% → 0.9%+571,310 shares
- Eog Res Inc~$131.3MNew · 0.0% → 0.5%+1,174,838 shares
- Cenovus Energy Inc~$130.3MNew · 0.0% → 0.5%+8,477,225 shares
Largest sells
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrPUT~$281.2MCut · 2.7% → 1.3%−787,300 underlying
- Uber~$191.6MCut · 0.6% → 0.0%−7,231,188 shares
- Conocophillips~$150.6MCut · 0.7% → 0.1%−1,471,400 shares
- Humana Inc~$146.4MCut · 0.7% → 0.1%−301,830 shares
- Coca Cola Co~$143.4MSold out · 0.6% → 0.0%−2,278,860 shares
- Argenx Se~$110.0MCut · 0.9% → 0.4%−311,667 shares
- Seagen Inc~$107.5MCut · 0.6% → 0.0%−785,622 shares
- Cigna Corp New~$107.3MCut · 0.7% → 0.2%−386,544 shares
- Gsk Plc~$106.9MSold out · 0.5% → 0.0%−2,454,999 shares
- Zoetis Inc~$104.4MCut · 0.7% → 0.1%−703,706 shares
Holdings
As of Sep 30, 2022. Changes are in shares against Jun 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Biogen IncCOM · shares +268% · price +30.9% | 1.8% | $448.0M | +$28.7M | ||||||||
| SPDR S&P 500 ETF TrPUTTR UNIT · shares −46% | 1.3% | $328.4M | — | ||||||||
| T-Mobile Us IncCOM · shares −20% · price −0.3% | 1.2% | $306.4M | −$844,797 | ||||||||
| AlibabaSPONSORED ADS · shares +490% · price −29.6% | 1.1% | $282.4M | −$20.2M | ||||||||
| Astrazeneca PlcSPONSORED ADR · shares +144% · price −17.0% | 1.1% | $263.9M | −$22.1M | ||||||||
| MetaCL A · shares +89% · price −15.9% | 1.0% | $262.1M | −$26.1M | ||||||||
| Fidelity Natl Information SvCOM · shares +68% · price −17.6% | 1.0% | $251.7M | −$32.0M | ||||||||
| Palo Alto NetworksCOM · shares +536% · price −66.8% | 0.92% | $231.6M | −$73.4M | ||||||||
| Arista NetworksCOM · shares +4.6% · price +20.4% | 0.89% | $223.3M | +$36.2M | ||||||||
| MicrosoftCOM · shares +148% · price −9.3% | 0.89% | $223.0M | −$9.2M | ||||||||
| AmazonCOM · shares +40% · price +6.4% | 0.83% | $207.7M | +$8.9M | ||||||||
| Visa Inc.COM CL A · shares −17% · price −9.8% | 0.82% | $204.9M | −$22.2M | ||||||||
| Analog DevicesCOM · shares +149% · price −4.6% | 0.79% | $198.2M | −$3.9M | ||||||||
| OracleCOM · shares +125% · price −12.6% | 0.73% | $183.7M | −$11.8M | ||||||||
| Take-Two Interactive SoftwarCOM · shares +2.6% · price −11.0% | 0.69% | $172.6M | −$20.9M | ||||||||
| Monster Beverage Corp NewCOM · shares +93% · price −6.2% | 0.69% | $172.1M | −$5.9M | ||||||||
| Juniper Networks IncCOM · shares +376% · price −8.4% | 0.65% | $163.4M | −$3.1M | ||||||||
| WorkdayCL A · shares New | 0.65% | $161.6M | — | ||||||||
| CrowdStrikeCL A · shares +0.9% · price −2.2% | 0.63% | $158.9M | −$3.6M | ||||||||
| PayPalCOM · shares +239% · price +23.2% | 0.61% | $152.5M | +$8.5M | ||||||||
| Select Sector SPDR TrENERGY · shares +52% · price +0.7% | 0.61% | $151.8M | +$708,694 | ||||||||
| Ross Stores IncCOM · shares +210% · price +20.0% | 0.59% | $146.8M | +$7.9M | ||||||||
| Bill Com Hldgs IncCOM · shares −15% · price +20.4% | 0.57% | $141.9M | +$24.0M | ||||||||
| Dell Technologies IncCL C · shares New | 0.56% | $139.3M | — | ||||||||
| Gsk PlcSPONSORED ADR · shares New | 0.54% | $136.0M | — | ||||||||
| Total · 1,372 positions | 100% | $25.04B | −$341.0M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2022 to Q3 2022: 646 stocks held throughout, down $341.0M (−2.8%).
- Arista Networks+$36.2M+20%
- Biogen Inc+$28.7M+31%
- Bill Com Hldgs Inc+$24.0M+20%
- Prometheus Biosciences Inc+$18.2M+109%
- Sarepta Therapeutics Inc+$15.1M+47%
- Meta−$26.1M−16%
- Avantor Inc−$27.0M−37%
- Fedex Corp−$27.3M−35%
- Fidelity Natl Information Sv−$32.0M−18%
- Palo Alto Networks−$73.4M−67%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $90.68B+16% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $78.05B−13% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $89.42B+50% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $59.76B+17% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $50.94B+16% | SEC ↗ |
| Q1 2025 | Jul 21, 2025 (amended) | $43.81B−3% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $45.39B+15% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $39.34B+3% | SEC ↗ |
| Q2 2024 | Sep 16, 2024 (amended) | $38.21B−7% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $41.26B−0% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $41.35B+21% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $34.27B+2% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $33.63B+4% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $32.29B+10% | SEC ↗ |
| Q4 2022 | May 15, 2023 (amended) | $29.42B+18% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $25.04B+6% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $23.70B−6% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $25.19B+1% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $25.04B+10% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $22.77B+2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $22.26B+4% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $21.41B+4% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $20.50B+5% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $19.53B+27% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $15.33B+25% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $12.31B−35% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $19.02B+17% | SEC ↗ |
| Q3 2019 | Nov 15, 2019 | $16.28B−15% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $19.11B−13% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $22.03B+8% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $20.48B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $24.25B−3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $25.06B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $23.92B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $23.17B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $22.41B+26% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $17.82B−1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $17.94B+25% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $14.30B+1% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $14.22B−3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $14.70B+13% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $13.04B | SEC ↗ |